AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimetop M 2 Tablet ER

Prescription Icon
Prescription Required

Marketer

RPG Life Sciences Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimetop M 2 Tablet ER

Diabetol Duo ER tablets are a dual-action antidiabetic medication, a combination therapy for adult patients with type 2 diabetes. This medication helps regulate blood glucose. Diabetol Duo ER should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medicine as prescribed, even if you feel well or your blood sugar is controlled. Stopping abruptly, without medical supervision, risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. Remember, it's one component of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to address them. Maintain regular meals and carry a quick-acting glucose source like sugary snacks or juice. Alcohol increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Disclose any history of heart disease to your physician before starting this treatment. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimetop M 2 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimetop M 2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the extended-release Glimetop M 2 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimetop M 2 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimetop M 2 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimetop M 2 Tablet ER should be administered with a meal.

How Glimetop M 2 Tablet ER works:

Glimetop M 2 Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimetop M 2 Tablet ER and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimetop M 2 tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimetop M 2 tablets are contraindicated for use while breastfeeding due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimetop M 2 Tablet ER cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimetop M 2 Tablet ER is contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimetop M 2 Tablet ER to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Initiate Glimetop M 2 Tablet ER therapy at a reduced dose for patients exhibiting mild to moderate liver dysfunction; its use is contraindicated in those with severe hepatic disease.

What if you forget to take Glimetop M 2 Tablet ER :

Should you forget a Glimetop M 2 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimetop M 2 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimetop M 2 Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimetop M 2 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimetop M 2 Tablet ER and seek immediate medical attention.
Glimetop M 2 Tablet ER combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimepiride ER (Glimetop M 2 Tablet ER) may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimepiride (Glimetop M 2 Tablet ER) can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Glimepiride (Glimetop M 2 Tablet ER) can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimetop M 2 Tablet ER and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimetop M 2 Tablet ER
76
MRP 93
17% off